Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 15, 2011 (Vol. 31, No. 18)

Can the FDA Be a Catalyst for Innovation?

New Commissioner Realigning Programs to Better Support Core Functions and Responsibilities

  • The FDA must be “a consistent catalyst for innovation,” insisted FDA commissioner Margaret Hamburg, M.D., in a July 13 letter to colleagues. That determination couldn’t come at a more critical time. The scientific, logistical, and administrative challenges are significant. “Innovative products that are truly transformative create unique scientific ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.